You can choose the size of the video you would like to embed below. Next, copy the embed code that is available in the box below. Paste this code on to your website to display the video.
If you experience problems embedding videos, please contact us.
Financial News Network
April 25, 2011 AT 7:17 PM
Health care shares are mixed to lower in mid-day trading while Merck (MRK) is seeing some downward pressure after the US Food and Drug Administration expressed concern over one of its experimental drugs. The FDA has said that it has seen possible anemia and psychiatric side effects in Merck's experimental hepatitis drug, boceprevir, according to Reuters. Meanwhile, Wells Fargo reportedly upgraded Johnson & Johnson (JNJ) to "outperform" from "market perform." The firm cited the company's consent decree with the FDA, four drug launches expected in the second half of 2011, and potential acquisition of Synthes.